Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- London
- Most recent report
- 6-K, filed Sep 9, 2026
- Filings on record
- 1,003+ filings
- On EDGAR
- CIK 1131399
- Filer status
- Large accelerated filer
Financials 8 of 914
- 6-K Report a foreign issuer made public elsewhere Sep 9, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 9, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 8, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 1, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 1, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 26, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 24, 2026
- 6-K Report a foreign issuer made public elsewhere Aug 24, 2026
Prospectuses and Registrations 8 of 11
- FWP Free writing prospectus Sep 9, 2026
- 424B2 Prospectus supplement for an offering Sep 8, 2026
- 25-NSE Notice that a security was delisted May 15, 2025
- 424B2 Prospectus supplement for an offering Mar 10, 2025
- FWP Free writing prospectus Mar 7, 2025
- 424B2 Prospectus supplement for an offering Mar 6, 2025
- 25-NSE Notice that a security was delisted Jun 3, 2024
- 25-NSE Notice that a security was delisted Oct 2, 2023
Ownership 8 of 39
- 144 Notice of a proposed sale of restricted stock Aug 20, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- 13F-HR Quarterly report of institutional holdings Aug 13, 2026
- 13F-HR Quarterly report of institutional holdings May 14, 2026
- SCHEDULE 13G Large holder reported a passive stake May 6, 2026
- 13F-HR Quarterly report of institutional holdings Feb 12, 2026
- 4 Insider reported a trade Dec 15, 2025
- SCHEDULE 13D/A Large holder reported an active stake, amended Dec 5, 2025
Other 8 of 39
Everything here comes from GSK plc's own filings on SEC EDGAR. The filing list is rechecked every hour.